Menu

Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6101208)

Tab Ubiquinol Acetate 100 mg,Inj Denosumab 60 mg,Tab Pomlidomide 2 mg,Tab Disopyramide 100 mg,Tab B

Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6101208)

Tender Timeline

Tender Issue
April 26, 2025 at 1:58 PM

Tender Title: Supply of Pharmaceutical Products
Tender Reference Number: GEM/2025/B/6101208
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The objective of this tender is to procure a variety of pharmaceutical products, specifically focusing on high-demand medications including Tab Ubiquinol Acetate 100 mg, Inj Denosumab 60 mg, Tab Pomlidomide 2 mg, and Tab Disopyramide 100 mg. This solicitation aims to ensure timely and consistent supply to healthcare facilities operated under the Department of Military Affairs, ensuring the health and welfare of military personnel and their families.

Scope of Work and Objectives

The successful contractor will be required to deliver a total quantity of 2,543 units spread across the specified categories of pharmaceutical products. The main objectives include ensuring the availability of quality medications and timely delivery to designated locations under the supervision of the Department of Military Affairs. The tender should cater to all specified requirements and comply with local regulations and quality assurance standards.

Eligibility Criteria

To qualify for this tender, bidders must be registered entities with a valid license for pharmaceutical distribution. Companies are required to demonstrate their capacity to supply the requested pharmaceuticals consistently over the course of the contract term. Experience in dealing with governmental healthcare procurement is an advantage.

Technical Requirements

Bidders must comply with several technical specifications:

  • Products should meet all the required safety and efficacy testing standards.
  • Documentation of quality assurance and control measures must be provided.
  • Suppliers should be able to guarantee a consistent supply chain, demonstrating proven logistics capabilities.

Financial Requirements

Detailed financial statements may be requested to ensure the bidder's capability to fulfill the contract obligations, including:

  • Proof of adequate financial resources.
  • Any required Performance Security to be submitted as part of the procurement process.

Document Submission Details

The submission of documents should be done electronically through the designated e-procurement platform. All required documentation, including technical bids, financial bids, and compliance certificates, must be submitted before the closing time specified in the tender announcement.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and provides various benefits to promote their involvement in government procurement processes. Additionally, provisions for startups are included to empower new entrants into the pharmaceutical supply chain.

Evaluation Process

Bids will be evaluated based on a set of structured criteria, including compliance with technical specifications, pricing competitiveness, and previous experience. Companies with assessed lower financial bids while meeting all requirements will be prioritized.

Delivery Locations

The delivered products are to be shipped to designated healthcare facilities determined by the Department of Military Affairs across various locations. Specific delivery addresses will be communicated upon award of the contract.

Contact Information

For any inquiries regarding this tender, please reach out to the Department of Military Affairs through the official communication channels provided in the tender announcement.

In conclusion, this tender invites eligible entities to participate in a critical supply chain that supports the health infrastructure for military personnel. By adhering to the outlined criteria and preparing comprehensive submissions, bidders have the opportunity to contribute to a vital service that affects the well-being of many.

General Information

Item Category
Tab Ubiquinol Acetate 100 mg , Inj Denosumab 60 mg , Tab Pomlidomide 2 mg , Tab Disopyramide 100 mg , Tab Bosentan 62.5mg , Tab cabozanitib 20mg , Inj Tocilizumab 162mg , Tab Ibandronate 150mg , Mercaptopurine 50mg , Syp Septran , Inj Evolocumab 140mg , Inj Adalimumab 40mg
Ministry Name
Organisation Name

Financial Information

Bid Offer Validity
120 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7696643.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Ketamine HCl 50 mg per ml 2 ml Inj,Bupivacaine HCl 5 mg per ml Inj,Fentanyl Citrate 50mcg per ml 2

GEM
Goods
Qty:33.9K
4 Files
Indian Army
KARGIL, JAMMU & KASHMIR
Boq › Boql
Ketamine HCl 50 mg per ml 2 ml Inj , Bupivacaine HCl 5 mg per ml Inj , Fentanyl Citrate 50mcg per ml 2 ml Inj , Dexamethasone 0.5 mg Tab , Baclofen 10 mg Tab , Inj Tenecteplase 20 mg , Enoxaparin 40 mg per 0.4ml Inj , Cilnidipine 5 mg Tab , Cap Probiotic , Itraconazole 100mg Cap , Oral Rehydration powder sachet of 20.5 g , Thyroxine Sodium 0.1mg Tab , Fluticasone Propionate 50 mcg BP Nasal Spray , Clonazepam 0.5 mg Tab , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg , Nortriptyline 25 mg Tab , Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule , Micronized Purified Flavonoid Fraction of rutaceae 500mg Tab , Tamsulosin HCl 0.4mg Cap , B1 50 mg Inj , Formeterol 6mcg and Budesonide 400 mcgC FC Free MDI 120 Meter dose , Levo- Salbutamol 1.25mg with Ipratropium 500 mcg in 2.5 ml Respule , Fexofenadine Hydrochloride Tab 120 mg , Amoxycillin 1g with Clavulanic Acid 200mg 1.2 gm Inj , Cefoperazone Sodium 1gm and sulbactum Sod 1gm Inj , Teicoplanin 400 mg Inj , Vancomycin CP 500 mg Inj , Meropenem 500 mg Inj , Gauze Surgical Open Wove Unmedicated 60 cm wide , HIV antibody 1 and 2 detection rapid test kit , Troponin T Test card , Rapid card screening for HBV kit of 50 test , Rapid card screening for HCV kit of 50 test , Tab Pantoprazole with Domperidone , Lyse solution, bott of 500ml , Cell Pack pack of 20 ltr , Tab Nilotinib 200mg , Syp Disodium Hydrogen Alkasol, bott of 100 ml , Dengue test card kit of 20 test , Malaria test card kit of 50 test , Typhi Dot test card kit of 50 test , Glucose strip Accu check , Glucometer Cell , Cap Diacerine 50mg , Medical Dry Film 10 inch and 8 inch Fujifilm , Sample Cup , Roter 180 Fully Automatic Machine Erba , Sodium Potassium Chloride kit 180 Fully Automatic , Cholestrol Kit 180 Fully Automatic Erba , Lipase Kit 180 Fully Automatic Erba , CKMB Kit 180 Fully Automatic Erba , CRP Kit 180 Fully Automatic Erba , LDH Kit 180 Fully Automatic Erba , Multi Cal Kit 180 Fully Automatic Erba , ERBA Auto Wash 180 Fully Automatic Erba , ERBA Norm 180 Fully Automatic Erba , ERBA Path 180 Fully Automatic Erba
April 26, 2025
May 17, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity with a valid pharmaceutical distribution license. Companies must demonstrate their ability to consistently supply the requested pharmaceutical products and must have prior experience in government healthcare procurement, showcasing their capability to meet compliance standards effectively.

Bidders are required to meet several technical specifications, which encompass safety and efficacy standards for all pharmaceutical products. Documentation showcasing quality assurance and control measures is essential. Additionally, bidders must demonstrate a reliable supply chain and logistics capability to ensure timely delivery of medications.

The Earnest Money Deposit (EMD) details will be specified in the tender documentation. Generally, bidders are required to submit an EMD to demonstrate their commitment to the procurement process. This deposit serves as a security measure, assuring that they will provide the necessary documentation and fulfill the tender requirements.

The evaluation and selection process will be structured and multifaceted, factoring in compliance with technical specifications, pricing competitiveness, and the overall experience of the bidding entity. Bidders with lower financial proposals that meet all criteria will hold an advantage in the selection phase.

Yes, this tender provides specific benefits for Micro, Small, and Medium Enterprises (MSEs) to encourage their participation. These benefits may include relaxed qualification criteria and targeted support mechanisms designed to foster greater involvement of MSEs in government procurement, ensuring they have equal opportunities to compete in the marketplace.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders